AMBUJACEM: Record sales and EBITDA growth, with focus on cost reduction and premiumization amid industry headwinds
AMBUJACEM: Record sales and EBITDA growth, with focus on cost reduction and premiumization amid industry headwinds
AMBUJACEM: Record sales and EBITDA growth, with focus on cost reduction and premiumization amid industry headwinds
Sector
BROAD_MARKET
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
POSITIVE
Published
08 May 2026
📎 Sources
Quartr | https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3282566:0-ambujacem-record-sales-and-ebitda-growth-with-focus-on-cost-reduction-and-premiumization-amid-industry-headwinds/